NCT03347201View on ClinicalTrials.gov

Thrombin Generation During Cardiopulmonary Bypass With Titrated Versus Conventional Anticoagulation Management.

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

March 5, 2019

Study Completion Date

May 28, 2019

Conditions
Cardiac Surgery
Interventions
DEVICE

HMS Plus

Subjects randomized to the intervention group will have their dose of Heparin and Protamine calculated by the HMS Plus.

Trial Locations (1)

M5G 2C4

Toronto General Hospital, University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03347201 - Thrombin Generation During Cardiopulmonary Bypass With Titrated Versus Conventional Anticoagulation Management. | Biotech Hunter | Biotech Hunter